These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11115819)

  • 1. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.
    Daniele B; Perrone F; Gallo C; Pignata S; De Martino S; De Vivo R; Barletta E; Tambaro R; Abbiati R; D'Agostino L
    Gut; 2001 Jan; 48(1):28-33. PubMed ID: 11115819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
    Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
    Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer.
    Daniele B; Secondulfo M; De Vivo R; Pignata S; De Magistris L; Delrio P; Palaia R; Barletta E; Tambaro R; Carratù R
    J Clin Gastroenterol; 2001 Mar; 32(3):228-30. PubMed ID: 11246350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study.
    Rotovnik Kozjek N; Kompan L; Soeters P; Oblak I; Mlakar Mastnak D; Možina B; Zadnik V; Anderluh F; Velenik V
    Clin Nutr; 2011 Oct; 30(5):567-70. PubMed ID: 21733605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.
    Okuno SH; Woodhouse CO; Loprinzi CL; Sloan JA; LaVasseur BI; Clemens-Schutjer D; Swan D; Axvig C; Ebbert LP; Tirona MR; Michalak JC; Pierson N
    Am J Clin Oncol; 1999 Jun; 22(3):258-61. PubMed ID: 10362332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial.
    Li Y; Yu Z; Liu F; Tan L; Wu B; Li J
    Tumori; 2006; 92(5):396-401. PubMed ID: 17168431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.
    Unger C; Häring B; Kruse A; Thumann A; Schneider B; Clemm C; Weber B; Clevert HD; Hockertz S; Kalousek MB
    Arzneimittelforschung; 2001; 51(4):332-8. PubMed ID: 11367875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
    Kozelsky TF; Meyers GE; Sloan JA; Shanahan TG; Dick SJ; Moore RL; Engeler GP; Frank AR; McKone TK; Urias RE; Pilepich MV; Novotny PJ; Martenson JA;
    J Clin Oncol; 2003 May; 21(9):1669-74. PubMed ID: 12721240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial.
    Leite RD; Lima NL; Leite CA; Farhat CK; Guerrant RL; Lima AA
    Arq Gastroenterol; 2013; 50(1):56-63. PubMed ID: 23657308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
    Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study.
    Bozzetti F; Biganzoli L; Gavazzi C; Cappuzzo F; Carnaghi C; Buzzoni R; Dibartolomeo M; Baietta E
    Nutrition; 1997; 13(7-8):748-51. PubMed ID: 9263281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Inhibits 5-Fluorouracil-induced Up-regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development.
    Sakai H; Kai Y; Oguchi A; Kimura M; Tabata S; Yaegashi M; Saito T; Sato K; Sato F; Yumoto T; Narita M
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):540-547. PubMed ID: 27194111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies.
    Hidalgo M; Villalona-Calero MA; Eckhardt SG; Drengler RL; Rodriguez G; Hammond LA; Diab SG; Weiss G; Garner AM; Campbell E; Davidson K; Louie A; O'Neil JD; von Borstel R; Von Hoff DD; Rowinsky EK
    J Clin Oncol; 2000 Jan; 18(1):167-77. PubMed ID: 10623707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
    Adjei AA; Reid JM; Diasio RB; Sloan JA; Smith DA; Rubin J; Pitot HC; Alberts SR; Goldberg RM; Hanson LJ; Atherton P; Ames MM; Erlichman C
    J Clin Oncol; 2002 Mar; 20(6):1683-91. PubMed ID: 11896120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.
    Chiara S; Nobile MT; Vincenti M; Lionetto R; Gozza A; Barzacchi MC; Sanguineti O; Repetto L; Rosso R
    Cancer Chemother Pharmacol; 1998; 42(4):336-40. PubMed ID: 9744780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
    Erlichman C; Fine S; Wong A; Elhakim T
    J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIO.
    Szelényi H; Hohenberger P; Lochs H; Haboubi N; Berdel WE; Thiel E; Kreuser ED
    Oncology; 2000 May; 58(4):273-9. PubMed ID: 10838491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.